Parity, Number of Pregnancies, and the Age of Onset of Alzheimer's Disease [6]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 16, Issue 1, 2004, Pages 120-121

  Sobow, Tomasz ^a   Kloszewska, Iwona ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; LETTER; ONSET AGE; PARITY; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR;

AGE OF ONSET; ALZHEIMER DISEASE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; NEUROPSYCHOLOGICAL TESTS; PARITY; PREGNANCY; REGRESSION ANALYSIS; RISK FACTORS;

EID: 1242329920     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.16.1.120     Document Type: Letter

References (5)

1. Thal LJ, Thomas RG, Mulnard R et al.: Estrogen levels do not correlate with improvement in cognition. Arch Neurol 2003; 60:209-12
2. Geerlings MI, Ruitenberg A, Witteman JC et al.: Reproductive period and risk of dementia in postmenopausal women. JAMA 2001; 285:1475-81
3. McLay RN, Maki PM, Lyketsos CG: Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci 2003:15:161-167
4. Sobow TM, Kutter EP, Kloszewska I: Hormonal decline indicator in women (age at menopause) modifies age of onset in sporadic Alzheimer's disease. Alzheimer Rep 1999; 2:27-30
5. Shumaker SA, Legault C, Thal L et al.: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289:2651-62